OpenAI has launched ChatGPT for Clinicians, a version of ChatGPT designed to support clinical tasks such as documentation, medical research, evidence review, and care consults. The company says the product is now available free to verified physicians, nurse practitioners, physician associates, and pharmacists in the United States.
According to OpenAI, ChatGPT for Clinicians includes trusted clinical search with cited answers, reusable skills for repeatable workflows, deep research across medical literature, optional HIPAA support through a Business Associate Agreement for eligible accounts, and the ability for eligible evidence review to count towards continuing medical education credits. OpenAI also says conversations in the product are not used to train models.
The launch builds on OpenAI’s earlier ChatGPT for Healthcare offering for organisations. OpenAI says clinicians across US health systems are already using that product for administrative work such as medical research and documentation, and describes the free clinician version as the next step in expanding access.
Alongside the launch, OpenAI has introduced HealthBench Professional, which it describes as an open benchmark for real-world clinician chat tasks across care consultation, writing, documentation, and medical research. The company says the benchmark is based on physician-authored conversations, multi-stage physician adjudication, and filtered examples selected for quality, representativeness, and difficulty.
OpenAI also says physician advisers reviewed more than 700,000 model responses in health scenarios, and that before release, clinicians tested 6,924 conversations across clinical care, documentation, and research.
According to the company, physicians rated 99.6% of those responses as safe and accurate, while GPT-5.4 in the ChatGPT for Clinicians workspace outperformed base GPT-5.4, other OpenAI and external models, and human physicians on HealthBench Professional. OpenAI adds that the tool is designed to support clinicians with information rather than replace their judgement or expertise.
The company says the free version is currently limited to verified US clinicians, with plans to expand access to additional countries and groups over time. OpenAI also says it will begin by working with the Better Evidence Network to pilot access for verified clinicians outside the United States, subject to local regulations, and has released a Health Blueprint with recommendations for responsible AI integration in US healthcare.
Why does it matter?
The launch of ChatGPT for Clinicians reflects a shift from general-purpose AI use in healthcare towards clinician-specific products tied to workflow, benchmarking, and compliance. It also shows that competition in medical AI is increasingly centred not only on model capability, but on safety evaluation, evidence retrieval, privacy controls, and integration into real clinical practice.
Would you like to learn more about AI, tech, and digital diplomacy? If so, ask our Diplo chatbot!